LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.33 | 771.67 | 6581 | 6392 | 1.0295 | 1.0191 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 51.55 | 771.67 | 8133 | 6829 | 1.1908 | 1.1142 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 51.55 | 771.67 | 7066 | 6829 | 1.0346 | 1.0217 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 53.77 | 771.67 | 8668 | 7256 | 1.1945 | 1.1130 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 53.77 | 771.67 | 7401 | 7256 | 1.0199 | 1.0122 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 55.99 | 771.67 | 9372 | 7690 | 1.2187 | 1.1229 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 55.99 | 771.67 | 7897 | 7690 | 1.0269 | 1.0161 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.21 | 771.67 | 9744 | 8085 | 1.2051 | 1.1132 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.21 | 771.67 | 8220 | 8085 | 1.0166 | 1.0098 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.44 | 771.67 | 10362 | 8530 | 1.2147 | 1.1154 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.44 | 771.67 | 8613 | 8530 | 1.0097 | 1.0056 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 62.66 | 771.67 | 10829 | 8978 | 1.2061 | 1.1087 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 62.66 | 771.67 | 9111 | 8978 | 1.0148 | 1.0083 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 64.88 | 771.67 | 11376 | 9447 | 1.2042 | 1.1055 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 64.88 | 771.67 | 9424 | 9447 | 0.9976 | 0.9986 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.10 | 771.67 | 11609 | 9800 | 1.1846 | 1.0945 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.10 | 771.67 | 9564 | 9800 | 0.9759 | 0.9867 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.32 | 771.67 | 12012 | 10212 | 1.1762 | 1.0891 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.32 | 771.67 | 9765 | 10212 | 0.9562 | 0.9761 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.54 | 771.67 | 12444 | 10532 | 1.1814 | 1.0904 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.54 | 771.67 | 9880 | 10532 | 0.9380 | 0.9664 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 73.76 | 771.67 | 12726 | 10851 | 1.1727 | 1.0853 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 73.76 | 771.67 | 10129 | 10851 | 0.9334 | 0.9642 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 76.02 | 771.67 | 13097 | 11106 | 1.1792 | 1.0875 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 76.02 | 771.67 | 10203 | 11106 | 0.9186 | 0.9564 | MN20160304_L01 | K07 |